Skip to main content
Year archive

4SC AG — 2016 filings

All 34 regulatory filings released by 4SC AG (VSC) in 2016, sourced directly from the official regulator.

34 Filings
2016 Period
2016 filings (34)
Filing Released Lang
4SC AG: First patient enrolled in pivotal RESMAIN study of resminostat in CTCL
Legal Proceedings Report
2016-12-16 English
4SC AG: 4SC provides Q3 2016 update
Earnings Release 9M 2016
2016-11-10 English
Q3 statement / Q3 financial report 2016
Interim / Quarterly Report 9M 2016
2016-11-10 English
4SC AG: Conference call to be hosted on 10 November 2016 to present 9M 2016 interim communication
Report Publication Announcement
2016-11-03 English
4SC AG: Dr Daniel Vitt to step down as CDO/CSO and from the Management Board at the end of 2016 | Dr Frank Hermann promoted to CDO and Dr Roland Baumgartner to CSO
Board/Management Information
2016-10-21 English
DGAP-DD: 4SC AG english
Director's Dealing
2016-10-06 English
4SC AG: Subgroup analysis suggests survival benefit in patients with advanced liver cancer treated with resminostat
Regulatory Filings
2016-10-05 English
4SC sells immunology portfolio to Immunic
M&A Activity
2016-09-28 English
4SC AG: Dr Jason Loveridge appointed new CEO of 4SC
Board/Management Information
2016-09-21 English
4SC AG: Dr Jason Loveridge appointed new CEO of 4SC
Board/Management Information
2016-09-21 English
Epigenetics: Reprogramming cancer - overcoming drug resistance | 11th 4SC Scientific Symposium
Regulatory Filings
2016-09-08 English
4SC provides operational and financial update for Q2 and 6M 2016
Earnings Release H1 2016
2016-08-11 English
Halbjahresfinanzbericht
Interim / Quarterly Report H1 2016
2016-08-11 German
Half-yearly financial report 2016
Interim / Quarterly Report H1 2016
2016-08-11 English
4SC AG: Conference call to be hosted on 11 August 2016 to present the consolidated half-year financial report 2016
Report Publication Announcement
2016-08-04 English
4SC forms international Scientific Expert Panel
Board/Management Information
2016-07-20 English
Resminostat boosts cancer immunotherapy
Regulatory Filings
2016-06-16 English
Konzernabschluss zum Geschäftsjahr vom 01.01.2015 bis zum 31.12.2015
Annual Report FY 2015
2016-06-15 German
Jahresabschluss zum Geschäftsjahr vom 01.01.2015 bis zum 31.12.2015
Audit Report / Information FY 2015
2016-06-14 German
4SC AG: 4SC at ASCO: 4SC 202 and checkpoint inhibitors - strong partners in cancer treatment
Regulatory Filings
2016-06-02 English
4SC AG: 4SC enters into licensing and development partnership with Link Health for the cancer compound 4SC 205 in China
M&A Activity
2016-05-31 English
4SC AG: 4SC provides headline results from Yakult Honsha's Phase II trial of resminostat in combination with sorafenib as first line therapy in liver cancer
Earnings Release FY 2016
2016-05-27 English
4SC reports on key events in Q1 2016
Earnings Release Q1 2016
2016-05-12 English
Q1 statement / Q1 financial report 2016
Interim / Quarterly Report Q1 2016
2016-05-12 English
4 SC AG: Bekanntmachung der Einberufung zur Hauptversammlung am 17.06.2016 in Planegg-Martinsried mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2016-05-09 German
4SC AG: Conference call to be hosted on 12 May 2016 to present Q1 2016 interim communication
Report Publication Announcement
2016-05-06 English
4SC AG: 4SC sells operations of its Discovery division
M&A Activity
2016-04-29 English
Annual financial report 2015
Annual Report FY 2015
2016-04-18 English
Annual financial report 2015
Annual Report FY 2015
2016-04-18 German
4SC AG: 4SC announces results for financial year 2015
Earnings Release FY 2015
2016-03-30 English
4SC AG: Chairman of the Management Board Enno Spillner will not extend his current term of office, but will leave the Company after a transitional period ending 30 June 2016
Board/Management Information
2016-03-24 English
4SC AG: Conference call to be hosted on 30 March 2016 to present annual results 2015
Report Publication Announcement
2016-03-23 English
Epigenetic compound 4SC-202 strengthens endogenous immune response to cancer
Regulatory Filings
2016-03-21 English
4SC AG: FDA approves IND application for resminostat in liver cancer
Regulatory Filings
2016-02-24 English